MedTrace Logo

Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis

NCT00669123 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2008-04-29

No results posted yet for this study

Summary

The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.

Conditions

Interventions

DRUG

Chondroitin sulphate

Chondroitin sulphate 800 mg/day

DRUG

Placebo

Sponsors & Collaborators

  • Bioiberica

    lead INDUSTRY

Principal Investigators

  • Pere Benito, MD · Hospital del Mar

  • Montserrat Pérez, MD · Instituto Poal de Reumatología

  • Ingrid Möller, MD · Instituto Poal de Reumatología

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00669123 on ClinicalTrials.gov